Form D — Laurentide Therapeutics Inc.
0002157396-26-000001 · filed Sep 28, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $100,000
- Total sold
- $99,999
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Laurentide Therapeutics Inc.
- CIK
- 2157396
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 2525 PEACHTREE RD
ATLANTA, GA 30305-3668 - Phone
- 4046801486
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Horace Nalle · Executive OfficerAtlanta, GA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗